Search for: "Cephalon Inc."
Results 41 - 60
of 169
Sorted by Relevance
|
Sort by Date
27 Feb 2009, 9:03 pm
Nonpracticing New Jersey physician Joseph Piacentile "now makes a living suing drug companies," and the new action in which his name figures against Forest Laboratories follows earlier suits he's helped instigate against Medco Health Solutions, Bristol-Myers Squibb, and Cephalon Inc.... [read post]
7 Jun 2008, 3:34 am
Included on our list were Cephalon, Inc., which spent $512,000, Abbott Laboratories, which spent $880,000, and Amgen Inc., which spent $2.5 million. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
16 Nov 2008, 9:29 pm
The Federal Drug Administration (FDA) is now warning doctors about severe skin reactions in alcoholism patients who use Vivitrol, an injectable treatment made and marked by Cephalon, Inc. [read post]
12 Dec 2009, 11:56 am
In Cephalon, Inc. v. [read post]
7 Aug 2006, 1:47 pm
Cephalon Inc. [read post]
6 Oct 2008, 3:54 pm
In a serious case of products liability, drug maker Cephalon, Inc. will pay $425 million in a settlement for illegally marketing a highly addictive lollipop painkiller and two other pharmaceuticals for non-approved uses. [read post]
2 Oct 2008, 10:18 pm
Drug maker Cephalon Inc. will pay $431 million to settle a number of whistleblower lawsuits accusing the company of promoting drugs for unapproved uses. [read post]
25 Aug 2009, 12:37 pm
In Cephalon, Inc. v. [read post]
20 Sep 2007, 3:04 pm
This medication, made by the drug company Cephalon, Inc., is prescribed to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea / hypopnea syndrome (OSAHS), and shift work sleep disorder. [read post]
12 Sep 2012, 1:46 pm
In Cephalon, Inc., et al. v. [read post]
10 Aug 2006, 2:59 pm
The Food and Drug Administration recently rejected approval of Cephalon Inc.'s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. [read post]
6 Jan 2022, 4:50 pm
Cephalon, Inc. [read post]
28 Aug 2017, 10:11 pm
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
5 Mar 2012, 10:30 am
Cephalon, Inc. v. [read post]
26 Dec 2009, 11:17 pm
Cephalon, Inc. v. [read post]
19 Oct 2009, 4:30 am
Cephalon Inc., No. [read post]
3 Jan 2019, 6:00 am
Cephalon, Inc., C.A. [read post]
3 Oct 2013, 7:07 am
Cephalon, Inc. et. al., 2-06-cv-02768 (PAED October 1, 2013, Order) (Goldberg, J.) [read post]
